• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Doxorubicin
    2 Drugs classified under this active ingredient

    All the Active Ingredient Drugs

    partial basket chart

    Anthracycline. Doxorubicin (HCl) 2 mg/ml.
    I.V. INFUS. (liposome inject.): 1. Ovarian
    cancer: 50 mg/m2 I.V at initial rate of 1
    mg/min. Incr. rate if no infus. related
    AE’s observed over 1 hr., every 4 wks.
    for as long as pt. does not progress,
    shows no signs cardiotox. and cont. tol.
    to tmt. 4 courses recommend. See lit.
    AIDS KS: 20 mg/m2 I.V. over 30 mins.
    once every 3 wks as long as pt.
    tolerates and responds.
    Monother. in metastat. breast cancer,
    where there is incr. cardiac risk. 1st or 2nd
    line ther. of AIDS-related Kaposis sarcoma in pts. with low cd 4 counts and extens. mucocutan. or visc. dis. Tmt. of pts with metastat. carcinoma of the ovary who are refract. to both paclitaxel and platinumbased chemother. regimens and who may also be refract. to topotecan. Refract. is defined as a pt. having progress. dis. while on tmt., or within 6 mths of completing tmt.

    Doxorubicin Teva
    partial basket chart
    Doxorubicin Teva

    Anthracycline. Doxorubicin HCl 2 mg/ml.
    VIALS (sol. for inject.): 25 ml, 100 ml.
    Recommend. total dose: 550 mg/m² I.V.
    See lit. Recommend. schedule: 60-75
    mg/m² as single I.V. at 21-day intervals.
    See lit.
    To produce regress. in dissem. neoplastic
    conds. e.g. acute lymphoblast. leuk., acute
    myeloblast. leuk., Wilms’ tumor, nblast.,
    soft tissue/bone sarc., carc. breast, ovary,
    transient cell bladder carc., thyroid carc.,
    lymph of both Hodgkin’s and non-
    Hodgkin’s bronchogen. carc., gastr. carc.